You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Takeda findings may minimise haemophilia treatment side effects

Immune responses against factor VIII (FVIII) – used to treat haemophilia A – are influenced by the microenvironment of antigen presenting cells.